Category
Cancer
Sub Category
Glioblastoma
Study Name
RTOG 1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Re-Irradiation Versus Bevacizumab Alone as Treatment of Recurrent Glioblastoma.
Principal Investigator
Gordan Srkalovic MD, PhD
Study Information
Contact for Questions
Sparrow Cancer Center 800-968-5570

Site view: at a glance